… Genital warts in young Australians five years into national human papillomavirus
vaccination programme: national surveillance data. BMJ 2013;346:f2032. https://doi.org/10.1136/bmj.…

… . Rapid decline in presentations of genital warts after the implementation of a national
quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect …

… in reducing incidence of genital warts even in opportunistic HPV vaccination structure. This
… providers in countries where national immunization programs do not include HPV vaccines. …

… of genital warts if they were to occur. Our aim was to determine if the national HPV vaccination
programme has had a measurable impact on clinical presentations of genital warts at a …

… evidence that the quadrivalent HPV vaccination program has led to a decreased management
rate of genital warts in general practice among those women of vaccine-eligible age. This …

… of data from a national sentinel surveillance system, we show that the national HPV
vaccination programme in Australia had a substantial effect on the clinical burden of genital warts. …

… of the quadrivalent HPV vaccine prospective study, HPV DNA was detected in 90.8% of
genital wart biopsy samples; of these samples, 94.7% were positive for LRHPV-6 and/or HPV-11 …

… of genital warts and incurred greater treatment costs than women. The quadrivalent vaccine,
the first vaccine to … cancer and genital warts, targets HPV types -6, and -11 (responsible for …

… -free periods, and the possibility of decreased infectivity, not only of HPV, but of other blood-…
genital warts. Furthermore, in very rare instances, HPV types normally found in genital warts …

… Reducing the number of doses in the human papillomavirus (HPV) vaccination regimen from
… genital warts (GWs) according to timing and number of doses of quadrivalent HPV vaccine. …